Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Katinko Calming - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Katinko Calming

Approved

STANDARD

Katinko Calming

Greenstone Pharmaceutical, Inc.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: adb4938165a43be5
Company: Greenstone Pharmaceutical, Inc.
Type: Standard

Approval Details

Approval Id: adb4938165a43be5
Drug Approval Philippines Name: Katinko Calming
Product Name: Katinko Calming
Registration Number: DRHR-2209
Brand Name: Katinko Calming
Generic Name: Methyl Salicylate + Menthol + Camphor
Dosage Form: Ointment (Lavender Scent)
Dosage Strength: 2 g/2 g/2 g per 100 g
Manufacturer: Greenstone Pharmaceutical, Inc.
Issuance Date: 27 February 2023
Expiry Date: 27 February 2028
Classification: Household Remedy (HR)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

adb4938165a43be5

Type

Standard

Back to Philippines FDA Approvals